Publication Document

Please enter search criteria

Document Type

Issuer / Underlying / Securities

Date From

The Financial Statements which need to be revised ( 0 record(s) found)

Order Date	Company Name	Reviewed Financial Statement	Details
Data not found

Finanacial Statements ( 48 record(s) found)

Name	Year	Status	Type	Period	As Of
DOD BIOTECH PUBLIC COMPANY LIMITED	2024	Reviewed	Company	Q1	31/03/2024
DOD BIOTECH PUBLIC COMPANY LIMITED	2024	Reviewed	Consolidated	Q1	31/03/2024
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Audited	Company	Year	31/12/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Audited	Consolidated	Year	31/12/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Reviewed	Company	Q3	30/09/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Reviewed	Consolidated	Q3	30/09/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Reviewed	Company	Q2	30/06/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Reviewed	Consolidated	Q2	30/06/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Reviewed	Company	Q1	31/03/2023
DOD BIOTECH PUBLIC COMPANY LIMITED	2023	Reviewed	Consolidated	Q1	31/03/2023

Key Financial Ratio ( 0 record(s) found)

Name	Year	As Of	Details
Data not found

Management's Discussion and Analysis ( 13 record(s) found)

Date	Time	Heading
09/05/2024	20:48	Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
23/02/2024	08:41	Management Discussion and Analysis Yearly Ending 31 Dec 2023
08/11/2023	19:33	Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
11/08/2023	08:33	Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
11/05/2023	21:36	Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023
22/02/2023	17:37	Management Discussion and Analysis Yearly Ending 31 Dec 2022
15/11/2022	20:07	Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022 (Revised)
10/11/2022	19:11	Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022
10/08/2022	21:30	Management Discussion and Analysis Quarter 2 Ending 30 Jun 2022
12/05/2022	19:24	Management Discussion and Analysis Quarter 1 Ending 31 Mar 2022

SEC has ordered to amend Finanacial Statements ( 0 record(s) found)

Name	Description	Details
Data not found